{"id":"W4307178199","doi":"10.1002/cncr.34463","title":"A phase 2 study of first‐line nivolumab in patients with locally advanced or metastatic cutaneous squamous‐cell carcinoma","year":2022,"lang":"en","type":"article","venue":"Cancer","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Nivolumab; Internal medicine; Clinical endpoint; Adverse effect; Response Evaluation Criteria in Solid Tumors; Oncology; Univariate analysis; Phases of clinical research; Ipilimumab; Toxicity; Surgery; Cancer; Gastroenterology; Immunotherapy; Clinical trial; Multivariate analysis","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006938796,0.000225865,0.0006176679,0.0001575018,0.0001129289,0.000003821983,0.0001455745,0.0000164163,0.0007584419],"category_scores_gemma":[0.00003437346,0.0001753201,0.00004291343,0.0005640934,0.00006791258,0.00004740588,0.0001399178,0.0002420779,0.000002004676],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006465479,"about_ca_system_score_gemma":0.0002947628,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000604794,"about_ca_topic_score_gemma":0.002673345,"domain_scores_codex":[0.9982283,0.00006235189,0.0004117853,0.0004114936,0.0005732368,0.0003128864],"domain_scores_gemma":[0.9990693,0.00009602892,0.0002060588,0.000399332,0.0001447135,0.00008459061],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02407582,0.01300596,0.9409416,0.0004153082,0.0001435074,0.001085599,0.005477496,0.002788409,0.00003157767,6.362729e-7,0.0005186272,0.01151545],"study_design_scores_gemma":[0.2961657,0.1597272,0.5179608,0.00025067,0.001346839,0.000102116,0.01578158,0.0009999097,0.001117143,0.00001342839,0.005499226,0.00103526],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961441,0.001177989,0.00002163571,0.00008881671,0.0001746746,0.002024682,0.0001203577,0.00002001019,0.0002277593],"genre_scores_gemma":[0.9979182,0.00001734255,0.0001822749,0.00014858,0.00003211936,0.0009260795,0.00001775308,0.00005196183,0.000705692],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4229807,"threshold_uncertainty_score":0.8304407,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01682327207268034,"score_gpt":0.2889173040255949,"score_spread":0.2720940319529145,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}